Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival among Patients with Stage III Colon Cancer: The CALGB/SWOG 80702 (Alliance) Randomized Clinical Trial

Jeffrey A. Meyerhardt, Qian Shi, Charles S. Fuchs, Jeffrey Meyer, Donna Niedzwiecki, Tyler Zemla, Priya Kumthekar, Katherine A. Guthrie, Felix Couture, Philip Kuebler, Johanna C. Bendell, Pankaj Kumar, Dequincy Lewis, Benjamin Tan, Monica Bertagnolli, Axel Grothey, Howard S. Hochster, Richard M. Goldberg, Alan Venook, Charles BlankeEileen M. O'Reilly, Anthony F. Shields

Research output: Contribution to journalArticlepeer-review

17 Scopus citations

Fingerprint

Dive into the research topics of 'Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival among Patients with Stage III Colon Cancer: The CALGB/SWOG 80702 (Alliance) Randomized Clinical Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences